People affected by a common inherited form of autism could be helped by a drug that is being tested as a treatment for cancer, according to researchers from the University of Edinburgh and McGill University.
Secondary Contact Information
Timing is everything: scientists control rapid re-wiring of brain circuits using patterned visual stimulation
In a new study, published in this week’s issue of the journal Science, researchers show for the first time how the brain re-wires and fine-tunes its connections differently depending on the relative timing of sensory stimuli. In most neuroscience textbooks today, there is a widely held model that explains how nerve circuits might refine their connectivity based on patterned firing of brain cells, but it has not previously been directly observed in real time.
We are honoured to host Dr. David Nicholas from the University of Calgary who is Canada's leading expert on issues of transitions to adulthood in autism. Dr. Nicholas will give a talk followed by a round table discussion.
Tensions in Parenting a Young Person with ASD: Examining Mothers' Experiences
Date: Thursday February 14
Time: 3:45 pm- 5:00 pm
Location: de Grandpré Communications Centre, Montreal Neurological Institute, 3801 rue University Montreal, QC H3A 2B4
MUHC Psychiatry Grand Rounds/RI-MUHC Mental Illness and Addiction Axis--The Emergence and Identification of Autism in Infancy
Special Guest Speaker
MUHC Psychiatry Grand Rounds RI-MUHC Mental Illness and Addiction Axis
Mayada Elsabbagh, Ph.D.
Assistant Professor in Psychiatry at McGill University
The Emergence and Identification of Autism in Infancy
Researchers from McGill University and the University of Montreal have identified a crucial link between protein synthesis and autism spectrum disorders (ASD), which can bolster new therapeutic avenues. Regulation of protein synthesis, also termed mRNA translation, is the process by which cells manufacture proteins. This mechanism is involved in all aspects of cell and organism function. A new study in mice has found that abnormally high synthesis of a group of neuronal proteins called neuroligins results in symptoms similar to those diagnosed in ASD. The study also reveals that autism-like behaviors can be rectified in adult mice with compounds inhibiting protein synthesis, or with gene-therapy targeting neuroligins. Their results are published in the journal Nature.